FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3183001230> ?p ?o ?g. }

• W3183001230 endingPage "232596712110213" @default.
• W3183001230 startingPage "232596712110213" @default.
• W3183001230 abstract "Genicular artery embolization (GAE) is an innovative technique that has been investigated as a supplementary treatment method for chronic pain secondary to knee osteoarthritis (OA).To evaluate the current evidence on the effectiveness and safety of GAE for OA-related knee pain.Systematic review; Level of evidence, 4.A systematic literature search was conducted in the PubMed, Web of Science, EMBASE, and Scopus databases to identify studies related to knee OA treated with GAE. Treatment agents were categorized as Embozene, imipenem/cilastatin, resorbable microspheres, and polyvinyl alcohol. The main outcomes were the mean difference (MD) in pre- and postembolization pain based on the visual analog scale (VAS) or the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) scores as well as changes in the need for pain medication. Random- and fixed-effects models were applied for data analysis.Of 379 initially inspected publications, 11 (N = 225 patients; 268 knees) were included in the final review. The quality of the studies was fair in 8 and poor in 3-categorized according to the National Institutes of Health quality assessment tool. Overall, 119, 72, 13, and 21 patients were treated with imipenem/cilastatin, Embozene, resorbable microspheres, and polyvinyl alcohol, respectively. Symptomatic improvement was reported in all studies. The pooled effect size, characterized by MD, showed a significant improvement in the VAS and WOMAC pain scores, with better functional status after GAE. Pre- versus postembolization MDs in VAS scores ranged from 32 within the first week to 58 after a 2-year follow-up (equivalent to 54% and 80% improvement, respectively). There was a similar trend in the overall WOMAC scores, with MDs ranging from 28.4 to 36.8 (about 58% and 85% improvement, respectively). GAE resulted in a decreased need for pain medication for knee OA, with a 27%, 65%, and 73% decline in the number of patients who used opioids, nonsteroidal anti-inflammatory drugs, and intra-articular hyaluronic acid injection, respectively (P < .00001 for all). No significant difference between embolic agents was seen with regard to post-GAE pain reduction. No severe or life-threatening complications were reported.OA treated by GAE using different embolic particles can be considered generally safe, with good efficacy and no reported serious complications." @default.
• W3183001230 created "2021-07-19" @default.
• W3183001230 creator A5016174233 @default.
• W3183001230 creator A5039378286 @default.
• W3183001230 creator A5044107299 @default.
• W3183001230 creator A5069474120 @default.
• W3183001230 creator A5073729629 @default.
• W3183001230 creator A5084195025 @default.
• W3183001230 creator A5088721828 @default.
• W3183001230 date "2021-07-01" @default.
• W3183001230 modified "2023-09-30" @default.
• W3183001230 title "Osteoarthritis-Related Knee Pain Treated With Genicular Artery Embolization: A Systematic Review and Meta-analysis" @default.
• W3183001230 cites W1985486228 @default.
• W3183001230 cites W1987537066 @default.
• W3183001230 cites W2025576343 @default.
• W3183001230 cites W2085788584 @default.
• W3183001230 cites W2087139148 @default.
• W3183001230 cites W2109577600 @default.
• W3183001230 cites W2131626977 @default.
• W3183001230 cites W2137510389 @default.
• W3183001230 cites W2167222800 @default.
• W3183001230 cites W2298897662 @default.
• W3183001230 cites W2341682349 @default.
• W3183001230 cites W2471765685 @default.
• W3183001230 cites W2512629239 @default.
• W3183001230 cites W2585795848 @default.
• W3183001230 cites W2601852041 @default.
• W3183001230 cites W2673540603 @default.
• W3183001230 cites W2741606776 @default.
• W3183001230 cites W2793296316 @default.
• W3183001230 cites W2804194569 @default.
• W3183001230 cites W2883582665 @default.
• W3183001230 cites W2900550641 @default.
• W3183001230 cites W2902807504 @default.
• W3183001230 cites W2905556635 @default.
• W3183001230 cites W2919109639 @default.
• W3183001230 cites W2920463645 @default.
• W3183001230 cites W2924406088 @default.
• W3183001230 cites W2930120446 @default.
• W3183001230 cites W2944676484 @default.
• W3183001230 cites W2956180049 @default.
• W3183001230 cites W2963787566 @default.
• W3183001230 cites W2996651219 @default.
• W3183001230 cites W3000012340 @default.
• W3183001230 cites W3000229516 @default.
• W3183001230 cites W3006803990 @default.
• W3183001230 cites W3007420257 @default.
• W3183001230 cites W3007976026 @default.
• W3183001230 cites W3013179658 @default.
• W3183001230 doi "https://doi.org/10.1177/23259671211021356" @default.
• W3183001230 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8287378" @default.
• W3183001230 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34350303" @default.
• W3183001230 hasPublicationYear "2021" @default.
• W3183001230 type Work @default.
• W3183001230 sameAs 3183001230 @default.
• W3183001230 citedByCount "27" @default.
• W3183001230 countsByYear W31830012302021 @default.
• W3183001230 countsByYear W31830012302022 @default.
• W3183001230 countsByYear W31830012302023 @default.
• W3183001230 crossrefType "journal-article" @default.
• W3183001230 hasAuthorship W3183001230A5016174233 @default.
• W3183001230 hasAuthorship W3183001230A5039378286 @default.
• W3183001230 hasAuthorship W3183001230A5044107299 @default.
• W3183001230 hasAuthorship W3183001230A5069474120 @default.
• W3183001230 hasAuthorship W3183001230A5073729629 @default.
• W3183001230 hasAuthorship W3183001230A5084195025 @default.
• W3183001230 hasAuthorship W3183001230A5088721828 @default.
• W3183001230 hasBestOaLocation W31830012301 @default.
• W3183001230 hasConcept C126322002 @default.
• W3183001230 hasConcept C141071460 @default.
• W3183001230 hasConcept C14184104 @default.
• W3183001230 hasConcept C142724271 @default.
• W3183001230 hasConcept C159110408 @default.
• W3183001230 hasConcept C17744445 @default.
• W3183001230 hasConcept C1862650 @default.
• W3183001230 hasConcept C189708586 @default.
• W3183001230 hasConcept C199539241 @default.
• W3183001230 hasConcept C204787440 @default.
• W3183001230 hasConcept C2776164576 @default.
• W3183001230 hasConcept C2779286237 @default.
• W3183001230 hasConcept C2779473830 @default.
• W3183001230 hasConcept C2779951463 @default.
• W3183001230 hasConcept C2780463824 @default.
• W3183001230 hasConcept C71924100 @default.
• W3183001230 hasConcept C95190672 @default.
• W3183001230 hasConceptScore W3183001230C126322002 @default.
• W3183001230 hasConceptScore W3183001230C141071460 @default.
• W3183001230 hasConceptScore W3183001230C14184104 @default.
• W3183001230 hasConceptScore W3183001230C142724271 @default.
• W3183001230 hasConceptScore W3183001230C159110408 @default.
• W3183001230 hasConceptScore W3183001230C17744445 @default.
• W3183001230 hasConceptScore W3183001230C1862650 @default.
• W3183001230 hasConceptScore W3183001230C189708586 @default.
• W3183001230 hasConceptScore W3183001230C199539241 @default.
• W3183001230 hasConceptScore W3183001230C204787440 @default.
• W3183001230 hasConceptScore W3183001230C2776164576 @default.
• W3183001230 hasConceptScore W3183001230C2779286237 @default.
• W3183001230 hasConceptScore W3183001230C2779473830 @default.

• next